GMT EIGHT - Announcement

ENVIRO ENERGY (01102) will be temporarily suspended from trading starting on January 22nd, awaiting the publication of insider information.

ENVIRO ENERGY (01102) announced that the trading of the company's shares on the Main Board of The Stock Exchange of Hong Kong Limited will be suspended from 9:00 am on January 22, 2025, pending the publication of announcements regarding the Hong Kong Code on Takeovers and Mergers and inside information of the company.

3 h ago

ENVIRO ENERGY (01102) will be temporarily suspended from trading starting January 22nd.

ENVIRO ENERGY (01102) has announced that trading of its shares will be temporarily suspended starting at 9:00 am on January 22, 2025.

3 h ago

Appointment of Jiang Kui as non-executive director and chairman of the board of Ferretti (09638)

FERRETTI (09638) announces that Jiang Kui has been appointed as a non-executive director and chairman of the board of directors at the shareholders' meeting, and his term of office is the same as that of other current directors (i.e. until the shareholders' meeting approving the financial statements for the fiscal year ended 31 December 2025).

3 h ago

LEPU BIO-B (02157) has entered into an exclusive licensing agreement for the innovative ADC MRG007.

LEPU BIO-B (02157) announces that on January 22, 2025, the company entered into an exclusive license agreement with ArriVent Biopharma, Inc. (listed on the NASDAQ global market with stock code: AVBP). According to the agreement, the company granted ArriVent an exclusive license to develop and commercialize the group's innovative antibody-drug conjugate MRG007 globally (excluding Greater China). Under the license agreement, the company granted ArriVent: (i) an exclusive license to the group's owned or controlled intellectual property related to MRG007 to develop, manufacture, and commercialize any product containing MRG007 in the licensed territory; and (ii) a non-exclusive license to the group's controlled intellectual property related to MRG007 to develop, manufacture, and commercialize any products for cancer treatment in the licensed territory. Subject to the terms and conditions of the license agreement, ArriVent is authorized to develop, manufacture, and commercialize MRG007 exclusively in the licensed territory. The company will receive a one-time upfront payment and near-term milestone payments totaling $47 million, as well as up to $1.16 billion in development, registration, and sales milestone payments, and high single-digit to low double-digit tiered royalties on net sales of MRG007 in the licensed territory in the future.

3 h ago

SKB BIO-B (06990) subscription structure deposit

SKB BIO-B (06990) announced that on January 21, 2025, the company entered into a structured deposit agreement III with CITIC BANK, whereby the company agreed to subscribe to a structured deposit in the amount of RMB 50 million. As of the date of this announcement, the total outstanding principal of the financial products purchased from CITIC BANK amounts to RMB 300 million. On January 21, 2025, the company also entered into structured deposit agreements IV (a) and IV (b) with China Zheshang Bank, whereby the company agreed to subscribe to two structured deposits, each with a principal amount of RMB 100 million. As of the date of this announcement, the total outstanding principal of the structured deposits held in China Zheshang Bank amounts to RMB 350 million. On January 21, 2025, the company also entered into a structured deposit agreement with China Merchants Bank, whereby the company agreed to subscribe to a structured deposit in the amount of RMB 200 million.

4 h ago

CHINA WATER (00855) plans to issue 1 billion yuan of guaranteed blue bonds with a maturity date in 2030 and an interest rate of 3.45%.

CHINA WATER (00855) announced that on January 21, 2025, the company entered into a subscription agreement with CGIF, joint global coordinators, joint bookrunners, and joint lead managers for the issuance of RMB 1 billion 3.45% guaranteed blue bond maturing in 2030. The company intends to use the net proceeds from the bond issuance to repay some offshore debts and follow its green and blue financing framework.

21/01/2025

Ganfeng Lithium Group (01772): Ganfeng Lithium intends to provide financial support to Shenzhen Yichu of not more than 500 million yuan.

Ganfeng Lithium Group (01772) announced that at the 88th meeting of the fifth board of directors held on January 21, 2025, the "Proposal on Ganfeng Lithium Battery Providing Financial Assistance to Shenzhen Easy Storage" was approved. In order to meet the financial needs of Shenzhen Easy Storage Energy Technology Co., Ltd. (hereinafter referred to as "Shenzhen Easy Storage") for business development, the company agreed that its holding subsidiary Jiangxi Ganfeng Lithium Battery Technology Co., Ltd. (hereinafter referred to as "Ganfeng Lithium Battery") will provide financial assistance to Shenzhen Easy Storage not exceeding RMB 500 million.

21/01/2025

ANTON OILFIELD(03337): In the fourth quarter, new orders increased by 26.51 billion yuan, a year-on-year increase of 73.4%.

ANTON OILFIELD (03337) announced that in the fourth quarter of 2024, due to trade tensions, geopolitical conflicts, and policy uncertainties, international oil prices fluctuated significantly, with Brent crude oil closing at $74.6 per barrel at the end of the year, remaining in the mid-high range. Market participants closely monitored the impact of the results of the U.S. presidential election on future energy policies and geopolitical dynamics. Meanwhile, there is a steady growth in natural gas demand, especially in the liquefied natural gas (LNG) market, with new projects continuously being launched to meet the strong demand in emerging markets such as the Asia-Pacific region, while also strengthening the diversification of the global natural gas supply chain. During the fourth quarter, the Group actively positioned itself for long-term future development, deeply penetrated global emerging oil and gas markets, and comprehensively promoted the landing of major breakthrough projects by continuously achieving breakthroughs in new fields through efficient technological applications and innovative business models. In this quarter, the Group focused on the natural gas industry chain, aimed at emerging market countries, to create localized solutions for the natural gas industry chain, and through a globalized industry chain, resources, and industry-leading technological capabilities, continually create value for customers and promote sustainable development. In the fourth quarter, the Group added new orders worth RMB 2.651 billion, an increase of 73.4% over the same period last year, with Iraq contributing approximately RMB 1.679 billion in new orders, a significant increase of 102.5% from the same period last year; other overseas markets added approximately RMB 41 million in new orders, down by 78.0% compared to the same period last year; and China added approximately RMB 0.931 billion in new orders, an increase of 81.4% from the same period last year. In the overseas market, the Group secured several substantial orders in Iraq during the quarter, including drilling large package service projects, CPF operation service projects, acid fracturing services, and oilfield operation and maintenance services, leading to a significant increase of 102.5% in new orders from the previous year. In other overseas markets, the Group secured drilling and well service projects, gas tightness testing service projects, but due to some large project orders still being in progress, new orders from other international emerging markets dropped by 78.0% compared to the previous year. In the Chinese market, the Group focused on regional market growth and continued to explore market opportunities, securing orders for fracking projects, platform drilling oil testing integrated construction service projects, downhole operations, and completion tool sales projects. In this quarter, new orders in the Chinese market increased by 81.4% compared to the same period last year. Order adjustments: At the end of the year, the Group conducted an overall review and settlement of all framework contracts (contracts that specify the project service scope and unit price at the time of signing, but are settled based on the actual work volume), leading to a reduction of RMB 38.8 million in orders for other overseas markets due to differences between the estimated annual workload and actual execution amount at the time of contract signing. As of December 31, 2024, the Group had approximately RMB 14.224 billion in hand orders, with Iraq accounting for approximately RMB 6.146 billion, representing about 43.2% of the total hand orders, other overseas markets accounting for approximately RMB 1.142 billion, representing about 8.0% of the total hand orders, and China accounting for approximately RMB 6.936 billion, representing about 48.8% of the total hand orders in the Group.

21/01/2025

Pharmaron Beijing (03759) expects a net profit attributable to the parent of approximately 1.729-1.857 billion yuan in 2024, an increase of 8%-16% year-on-year.

Pharmaron Beijing (03759) announced that it is expected to achieve revenue of approximately 11.9995 billion to 12.346 billion yuan in 2024, a year-on-year growth of 4% to 7%; net profit attributable to shareholders of the listed company is expected to be around 1.729 billion to 1.857 billion yuan, a year-on-year growth of 8% to 16%; non-GAAP net profit is expected to be around 1.075 billion to 1.151 billion yuan, a year-on-year decrease of 24% to 29%; adjusted net profit is expected to be around 1.561 billion to 1.656 billion yuan, a year-on-year decrease of 13% to 18%. With the initial recovery of global biopharmaceutical industry investment and financing, the company achieved growth in both quarter-on-quarter and year-on-year operating income in the second and third quarters. Additionally, due to the timely delivery of CMC (small molecule CDMO) service projects, the company's fourth quarter operating income is expected to further accelerate year-on-year growth. Based on the estimated median value in the performance forecast, the company's fourth quarter operating income is expected to increase by 4% quarter-on-quarter and by 13% year-on-year. Overall for the year, it is projected that the company's operating income will increase by 4% to 7% year-on-year; global customer inquiries and visits have shown some improvement compared to the same period in 2023, with new order amounts increasing by over 20% year-on-year. Due to the slight increase in operating income year-on-year, growth in personnel in the second half of 2023 and during the reporting period, additional syndicated loans obtained at the end of 2023, and new production capacity coming online, the net profit attributable to shareholders of the listed company, after deducting non-recurring gains and losses, is expected to decrease by 24% to 29% compared to the same period last year; adjusted net profit attributable to shareholders of the listed company under non-International Financial Reporting Standards is expected to decrease by 13% to 18% compared to the same period last year.

21/01/2025

China Shenhua Energy (01088) plans to invest 200 million yuan to establish Guoneng Yishang Electronic Commerce (Beijing) Co., Ltd.

China Shenhua Energy (01088) announced that the board of directors approved China Shenhua Energy to establish a wholly-owned subsidiary, Guoneng Yishang E-commerce (Beijing) Co., Ltd. with a cash investment of 200 million yuan (tentative name, subject to final approval by the market supervision department).

21/01/2025

Contact: contact@gmteight.com